Check out our news archive below to learn more about what’s happening in Duke Psychiatry & Behavioral Sciences!
Learning to Understand Health Through the Eyes of the Patient
What does it mean to follow a physician's recommendations when healthy food is unaffordable; transportation is unreliable, or essential resources are out of reach?
Duke to Play Key Role in $13 Million PCORI-Funded Study of Symptom Management for Cholestatic Liver Diseases
Duke Psychiatry's Rebecca Shelby, PhD, and Tamara Somers, PhD, will lead the clinical coordinating center for a $13 million, five-year study funded by the Patient-Centered Outcomes Research Institute (PCORI). The study will aim to improve symptom management and quality of life for adults living with rare cholestatic liver diseases.
A blind spot in e-cigarette research
A study led by Duke Psychiatry's Joseph McClernon, PhD, found that more than 80% of smoking-cessation trials did not report whether participants continued smoking while vaping, raising questions about whether e-cigarettes truly help people quit.
Five tips to boost wellbeing
Duke psychologist Bryan Sexton, PhD, shares simple, research-backed practices that can improve well-being, reduce burnout, and fit into even the busiest schedules.
Sozosei Foundation Grant Will Expand Duke Leadership on Psychiatric Advance Directives
A new $100,000 grant from the Sozosei Foundation will support the Wilson Center for Science and Justice at Duke Law in expanding access to Psychiatric Advance Directives, an area of expertise for Marvin Swartz, MD, professor of psychiatry and behavioral sciences and lead of the Wilson Center's Behavioral Health Team.
Building Community, Support & Skills for Youth Living with Chronic Illness
On a sweltering day in July, 15 young adults stayed cool as they gathered in a meeting space in Trinity House, a dorm on Duke’s East Campus, to talk about how to best use their often-limited energy
Real-World Study Provides New Insights into Safety of New Alzheimer’s Drug
Duke Health researchers including Duke Psychiatry's P. Murali Doraiswamy, MBBS, studied more than 230 patients treated with lecanemab, a new FDA-approved therapy designed to remove a protein linked to Alzheimer’s disease from the brain. They found the therapy’s real-world safety, treatment persistence, and effects on disease progression aligned with results from clinical trials.
To Improve Health, Look to the Community
In her new book, "America’s Health," Duke Psychiatry's Leslie Bronner, MD, DrPH, calls attention to the outsize impact of community conditions on our health and the need for policies and systems that better support our wellbeing. The book weaves together research, fresh ideas, and engaging vignettes drawn from Bronner’s clinical experiences.
Financial stress linked to suicide risk among veterans
A JAMA Network Open study led by Duke Psychiatry's Eric Elbogen, PhD, found that veterans experiencing major financial strain were significantly more likely to die by suicide within the following year than those without financial difficulties.
Bringing the World to Duke and Duke to the World
The Duke Center for Autism & Brain Development's monthly seminar series started as a small faculty gathering in 2014. Today the series, now virtual and open to the public, brings leading experts into conversation with a global audience.